FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) completed its de-SPAC business combination in September 2022 through a merger with CF Acquisition Corp. VIII, a blank-check company sponsored by an affiliate of Cantor Fitzgerald. The underlying SPAC conducted its IPO in 2021, targeting the technology and financial services sectors. FOXO operates in the insurtech space, applying epigenetic biomarker research and longevity science to life insurance underwriting and product innovation. The September 15, 2022 Form 8-K filing marks the consummation of that transaction, transitioning FOXO from a private company to a publicly traded issuer. Visit SpacDesk and sign up for full data, filings, and analytics on FOXO and hundreds of other SPAC transactions.